These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16316769)

  • 21. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan.
    Nelson JB; Nabulsi AA; Vogelzang NJ; Breul J; Zonnenberg BA; Daliani DD; Schulman CC; Carducci MA
    J Urol; 2003 Mar; 169(3):1143-9. PubMed ID: 12576870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic science and clinical utility of biochemical markers of bone turnover--a Congress report.
    Seibel MJ; Baylink DJ; Farley JR; Epstein S; Yamauchi M; Eastell R; Pols HA; Raisz LG; Gundberg CM
    Exp Clin Endocrinol Diabetes; 1997; 105(3):125-33. PubMed ID: 9228507
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
    Woitge HW; Seibel MJ
    Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guideline for adequate use of metabolic bone markers in osteoporosis].
    Nishizawa Y; Nakatsuka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():325-32. PubMed ID: 15035146
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
    Nishizawa Y; Nakamura T; Ohta H; Kushida K; Gorai I; Shiraki M; Fukunaga M; Hosoi T; Miki T; Chaki O; Ichimura S; Nakatsuka K; Miura M;
    J Bone Miner Metab; 2005; 23(2):97-104. PubMed ID: 15750686
    [No Abstract]   [Full Text] [Related]  

  • 26. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
    Akesson K; Käkönen SM; Josefsson PO; Karlsson MK; Obrant KJ; Pettersson K
    J Bone Miner Metab; 2005; 23(1):30-5. PubMed ID: 15616891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical markers of bone turnover in percutaneous vertebroplasty for osteoporotic compression fracture.
    Komemushi A; Tanigawa N; Kariya S; Kojima H; Shomura Y; Tokuda T; Nomura M; Terada J; Kamata M; Sawada S
    Cardiovasc Intervent Radiol; 2008; 31(2):332-5. PubMed ID: 18074174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical markers of bone turnover.
    Rosalki SB
    Int J Clin Pract; 1998 Jun; 52(4):255-6. PubMed ID: 9744151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women.
    Gass ML; Kagan R; Kohles JD; Martens MG
    Menopause; 2008; 15(4 Pt 1):667-75. PubMed ID: 18327152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The assessment of bone metabolism in vivo using biochemical approaches.
    Russell RG
    Horm Metab Res; 1997 Mar; 29(3):138-44. PubMed ID: 9137985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.
    Viapiana O; Gatti D; Dalle Grave R; Todesco T; Rossini M; Braga V; Idolazzi L; Fracassi E; Adami S
    Bone; 2007 Apr; 40(4):1073-7. PubMed ID: 17240212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical markers of bone turnover in osteoporosis.
    Delmas PD; Beaudreuil J
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):31S-36S. PubMed ID: 9273935
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone remodeling and calcium homeostasis in patients with spinal cord injury: a review.
    Maïmoun L; Fattal C; Sultan C
    Metabolism; 2011 Dec; 60(12):1655-63. PubMed ID: 21632079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in bone turnover markers during 14-day 6 degrees head-down bed rest.
    Kim H; Iwasaki K; Miyake T; Shiozawa T; Nozaki S; Yajima K
    J Bone Miner Metab; 2003; 21(5):311-5. PubMed ID: 12928833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk.
    Clowes JA; Eastell R
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):213-32. PubMed ID: 11035903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.